Skip to playerSkip to main content
  • 21 hours ago

Category

People
Transcript
00:00Researchers identify sugar molecule linked to Alzheimer's disease.
00:05Johns Hopkins researchers discovered a sugar molecule, glycan,
00:09possibly crucial in Alzheimer's development, from the brain tissues of deceased patients.
00:14Identifying glycan as an early diagnostic test target is essential for creating treatments
00:19and preventative measures for this common dementia form.
00:22Alzheimer's disease progressively results from brain nerve cell death,
00:29caused by harmful protein buildup like tau and amyloid.
00:33Microglia, the brain's immune cells, clean these proteins.
00:37The disease develops when microglia's cleanup fails due to excess CD33 receptors.
00:45The study led by Ronald Schnarr found that receptors need connectors
00:49to block microglia from clearing toxic proteins.
00:53These connectors are sugars called glycans, transported by proteins to receptors,
00:58forming a glycoprotein, crucial in Alzheimer's disease research.
01:04Glycans consist of unique sugar components influencing molecular interactions.
01:10The team used chemical techniques to systematically deconstruct the glycan,
01:14identifying it as the allylated keratin sulfate.
01:16They pinpointed the protein component using mass spectroscopy to detect its building blocks.
01:25The team identified the glycoprotein as receptor tyrosine phosphatase zeta,
01:31naming it RPTP-zeta-S3L.
01:37Researchers found that Alzheimer's brains had over twice the amount of RPTP-zeta-S3L,
01:43which may over-activate CD33 receptors and impair toxic protein clearance.
01:49Studying its structure could lead to new treatments or early diagnostic tools.
Be the first to comment
Add your comment

Recommended